...
首页> 外文期刊>Planta medica: Natural products and medicinal plant research >Presence of antispasmodic, antidiarrheal, antisecretory, calcium antagonist and acetylcholinesterase inhibitory steroidal alkaloids in Sarcococca saligna.
【24h】

Presence of antispasmodic, antidiarrheal, antisecretory, calcium antagonist and acetylcholinesterase inhibitory steroidal alkaloids in Sarcococca saligna.

机译:sarcococa saligna中存在解痉,止泻,抗分泌,钙拮抗剂和乙酰胆碱酯酶抑制类固醇生物碱。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this investigation was to see if the crude extract of Sarcococca saligna (Ss.Cr) contains chemicals with gut function inhibitory activity by using in vitro and in vivo assays. Ss.Cr caused a dose-dependent (0.03 - 3 mg/mL) inhibitory effect on K+-induced contractions in rat stomach fundus, guinea-pig ileum and rabbit jejunum preparations. The calcium channel blocking(CCB) activity was confirmed when Ss.Cr caused a rightward shift in the Ca++ dose-response curves. It also potentiated, at lower do-ses (0.001 - 0.03 mg/mL), the contractile effect of a fixed dose of acetylcholine (ACh), similar to physostigmine, and suppressed the effect of ACh at higher doses (0.3 - 1.0 mg/mL). Both Ss.Cr and physostigmine inhibited acetylcholinesterase (AChE), in the in vitro assay, confirming the AChE inhibitory activity. In the in vivo studies, Ss.Cr exhibited antidiarrheal and antisecretory activities against castor oil-induced diarrhea and intestinal fluid accumulation in mice. Characteristic steroidal compounds of the plant (saracocine, saracodine, saracorine and alkaloid-C), exhibited a similar combination of AChE inhibitory and CCB activities. Thus this study provides a sound mechanistic base for some of the traditional uses of the plant in hyperactive gut states, in addition to providing the first evidence for verapamil to possess additional AChE inhibitory activity. Furthermore, these characteristic compounds with dual activity may be good candidates for further studies on their usefulness in Alzheimer's disease.
机译:这项研究的目的是通过体外和体内试验来观察Sarcococca saligna(Ss.Cr)的粗提物中是否含有具有肠功能抑制活性的化学物质。 Ss.Cr对大鼠胃底,豚鼠回肠和兔空肠制剂中K +诱导的收缩产生剂量依赖性(0.03-3 mg / mL)抑制作用。当Ss.Cr引起Ca ++剂量反应曲线向右移动时,证实了钙通道阻滞(CCB)活性。它也以较低剂量(0.001-0.03 mg / mL)增强了与毒扁豆碱相似的固定剂量乙酰胆碱(ACh)的收缩作用,并抑制了较高剂量(0.3-1.0 mg / mL)时ACh的作用。毫升)。在体外测定中,Ss.Cr和毒扁豆碱均抑制乙酰胆碱酯酶(AChE),证实了AChE的抑制活性。在体内研究中,Ss.Cr对小鼠蓖麻油引起的腹泻和肠液积聚表现出止泻和抗分泌活性。植物的特征类固醇化合物(saracocine,saracodine,saracorine和生物碱-C)表现出类似的AChE抑制活性和CCB活性组合。因此,该研究除了为维拉帕米具有额外的AChE抑制活性提供了第一个证据外,还为该植物在肠道过度活跃状态下的某些传统用途提供了可靠的机制基础。此外,这些具有双重活性的特征化合物可能是进一步研究其在阿尔茨海默氏病中用途的良好候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号